NPI: 1306015425 · HUNTINGTON BEACH, CA 92647 · Federally Qualified Health Center (FQHC) · NPI assigned 02/22/2008
Authorized official YOUNG, ROBERT controls 20+ related entities in our dataset. Read more
| Authorized Official | YOUNG, ROBERT (VP, PATIENT FINANCIAL SERVICES) |
| NPI Enumeration Date | 02/22/2008 |
Other providers sharing the same authorized official: YOUNG, ROBERT
| Year | Claims | Total Paid |
|---|---|---|
| 2018 | 1,320,076 | $7.74M |
| 2019 | 543,773 | $6.36M |
| 2020 | 92,017 | $6.75M |
| 2021 | 121,885 | $8.00M |
| 2022 | 116,291 | $6.81M |
| 2023 | 147,833 | $9.48M |
| 2024 | 162,985 | $8.17M |
| Code | Description | Claims | Beneficiaries | Total Paid |
|---|---|---|---|---|
| T1015 | Clinic visit/encounter, all-inclusive | 240,945 | 212,445 | $41.36M |
| 00003 | Internal/system code - not a standard HCPCS code | 41,586 | 39,414 | $9.97M |
| 99213 | Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 358,713 | 303,982 | $556K |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | 62,267 | 52,115 | $298K |
| 99394 | Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) | 6,234 | 5,152 | $114K |
| 99214 | Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 65,546 | 60,125 | $103K |
| 99393 | Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) | 9,021 | 7,832 | $101K |
| 99392 | Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) | 10,964 | 9,689 | $85K |
| 99391 | Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) | 5,593 | 4,761 | $79K |
| 90834 | Psychotherapy, 45 minutes with patient | 4,804 | 3,126 | $67K |
| 96110 | Developmental screening, with scoring and documentation, per standardized instrument | 1,950 | 1,621 | $43K |
| 90686 | 45,354 | 42,801 | $36K | |
| H1001 | Prenatal care, at-risk enhanced service; antepartum management | 3,898 | 2,913 | $35K |
| G0467 | Federally qualified health center (fqhc) visit, established patient; a medically-necessary, face-to-face encounter (one-on-one) between an established patient and a fqhc practitioner during which time one or more fqhc services are rendered and includes a typical bundle of medicare-covered services that would be furnished per diem to a patient receiving a fqhc visit | 1,484 | 1,169 | $32K |
| G2025 | Payment for a telehealth distant site service furnished by a rural health clinic (rhc) or federally qualified health center (fqhc) only | 1,971 | 1,707 | $31K |
| 99396 | Periodic comprehensive preventive medicine reevaluation, established patient, 40-64 years | 3,591 | 2,970 | $31K |
| 92250 | 2,067 | 2,064 | $31K | |
| 90832 | Psychotherapy, 30 minutes with patient | 1,089 | 524 | $25K |
| J3490 | Unclassified drugs | 964 | 819 | $24K |
| 90791 | Psychiatric diagnostic evaluation | 947 | 749 | $24K |
| 90677 | 1,013 | 809 | $21K | |
| 90715 | 7,978 | 6,869 | $18K | |
| 99395 | Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years | 3,269 | 3,089 | $17K |
| 90739 | 640 | 592 | $13K | |
| 87811 | Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) | 1,248 | 860 | $12K |
| 99203 | Office or other outpatient visit for the evaluation and management of a new patient, low complexity | 2,705 | 2,675 | $12K |
| 90651 | 5,314 | 4,610 | $10K | |
| 99202 | Office or other outpatient visit for the evaluation and management of a new patient, straightforward | 4,682 | 3,965 | $10K |
| 92551 | 18,916 | 16,502 | $9K | |
| 90670 | 5,833 | 5,152 | $8K | |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | 15,537 | 13,947 | $8K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | 3,425 | 2,650 | $8K |
| 0011A | 137 | 78 | $7K | |
| 85018 | 26,568 | 23,333 | $6K | |
| 0012A | 121 | 75 | $6K | |
| 90633 | 3,522 | 3,032 | $5K | |
| 90656 | 1,515 | 1,041 | $5K | |
| 90680 | 2,163 | 1,966 | $5K | |
| 83655 | 3,764 | 3,288 | $5K | |
| 90698 | 2,543 | 2,238 | $4K | |
| G9920 | Screening performed and negative | 2,538 | 1,652 | $4K |
| G0071 | Payment for communication technology-based services for 5 minutes or more of a virtual (non-face-to-face) communication between an rural health clinic (rhc) or federally qualified health center (fqhc) practitioner and rhc or fqhc patient, or 5 minutes or more of remote evaluation of recorded video and/or images by an rhc or fqhc practitioner, occurring in lieu of an office visit; rhc or fqhc only | 1,558 | 1,387 | $4K |
| 90734 | 2,661 | 2,349 | $4K | |
| H1003 | Prenatal care, at-risk enhanced service; education | 5,662 | 4,343 | $4K |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | 4,059 | 2,855 | $4K |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | 1,730 | 1,621 | $4K |
| 81025 | 13,247 | 12,252 | $3K | |
| 90744 | 1,617 | 1,448 | $3K | |
| S9445 | Patient education, not otherwise classified, non-physician provider, individual, per session | 1,531 | 1,240 | $3K |
| 90688 | 2,640 | 2,613 | $2K | |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | 9,890 | 9,306 | $2K |
| 83036 | Hemoglobin; glycosylated (A1C) | 33,776 | 32,504 | $2K |
| 99385 | 539 | 524 | $2K | |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | 546 | 523 | $2K |
| 99215 | Prolong outpt/office vis | 264 | 239 | $2K |
| 90710 | 1,250 | 1,113 | $2K | |
| 81002 | 34,011 | 26,691 | $2K | |
| 90658 | 161 | 151 | $1K | |
| 85999 | 492 | 473 | $1K | |
| 0064A | 28 | 15 | $1K | |
| 99384 | 287 | 216 | $1K | |
| 90716 | 991 | 825 | $1K | |
| 90696 | 892 | 754 | $1K | |
| 96156 | 536 | 529 | $874.87 | |
| 1126F | 149,086 | 139,224 | $853.95 | |
| 99173 | 17,216 | 15,161 | $810.78 | |
| 90707 | 911 | 769 | $721.13 | |
| 99401 | 1,856 | 1,550 | $706.67 | |
| 90697 | 946 | 764 | $684.00 | |
| 90732 | 572 | 508 | $649.86 | |
| 90472 | Immunization administration, each additional vaccine (list separately) | 1,168 | 1,094 | $623.48 |
| 90746 | 718 | 543 | $615.30 | |
| 90700 | 868 | 748 | $612.00 | |
| 90480 | 192 | 139 | $480.40 | |
| 90681 | 132 | 97 | $468.00 | |
| 90671 | 367 | 316 | $464.68 | |
| 90685 | 1,509 | 1,434 | $416.39 | |
| G9012 | Other specified case management service not elsewhere classified | 646 | 236 | $413.81 |
| 82962 | 4,000 | 3,395 | $381.42 | |
| 99383 | 324 | 264 | $353.65 | |
| 97803 | 729 | 695 | $336.40 | |
| 11721 | 151 | 145 | $302.25 | |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | 31,136 | 28,200 | $300.97 |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | 1,974 | 1,697 | $248.33 |
| 99382 | 67 | 47 | $243.20 | |
| 36415 | Collection of venous blood by venipuncture | 21,857 | 21,201 | $227.56 |
| 86580 | 1,357 | 1,280 | $214.94 | |
| 90648 | 1,125 | 957 | $211.04 | |
| 0124A | 15 | 15 | $201.00 | |
| 90750 | 12 | 12 | $176.03 | |
| 90619 | 452 | 379 | $126.00 | |
| 99243 | 319 | 317 | $124.41 | |
| G8510 | Screening for depression is documented as negative, a follow-up plan is not required | 53,002 | 49,905 | $117.70 |
| 90649 | 15 | 13 | $90.00 | |
| 36416 | 9,841 | 9,183 | $86.22 | |
| J1050 | Injection, medroxyprogesterone acetate, 1 mg | 32 | 25 | $85.51 |
| 90713 | 187 | 161 | $72.00 | |
| 0144A | 15 | 15 | $67.00 | |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | 1,050 | 1,009 | $56.97 |
| 87389 | Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies | 9,886 | 9,784 | $41.70 |
| 80061 | Lipid panel | 24,582 | 24,410 | $34.62 |
| H2000 | Comprehensive multidisciplinary evaluation | 280 | 279 | $33.64 |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | 18,820 | 17,422 | $31.07 |
| 84443 | Thyroid stimulating hormone (TSH) | 16,570 | 16,365 | $29.52 |
| 80053 | Comprehensive metabolic panel | 29,268 | 28,903 | $27.84 |
| 90723 | 161 | 152 | $27.00 | |
| 99000 | 1,838 | 1,593 | $25.41 | |
| 96151 | 497 | 462 | $22.50 | |
| 81000 | 162 | 158 | $17.22 | |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | 500 | 440 | $14.76 |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 24,115 | 23,777 | $13.50 |
| 86803 | 3,720 | 3,700 | $12.57 | |
| T1013 | Sign language or oral interpretive services, per 15 minutes | 245 | 214 | $10.56 |
| 81001 | 5,121 | 5,012 | $9.08 | |
| 90460 | Immunization administration through 18 years of age via any route, first or only component | 12,494 | 11,431 | $9.00 |
| 92015 | Determination of refractive state | 13 | 13 | $8.01 |
| 87070 | 789 | 777 | $7.95 | |
| 85027 | 2,179 | 2,163 | $5.71 | |
| 87086 | Culture, bacterial; quantitative colony count, urine | 4,503 | 4,337 | $2.21 |
| 82570 | 8,434 | 8,325 | $0.61 | |
| J7613 | Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg | 16 | 12 | $0.24 |
| 1160F | 98,143 | 91,228 | $0.00 | |
| J7610 | Albuterol, inhalation solution, compounded product, administered through dme, concentrated form, 1 mg | 1,108 | 1,008 | $0.00 |
| J8499 | Prescription drug, oral, non chemotherapeutic, nos | 1,578 | 1,519 | $0.00 |
| 69210 | 400 | 385 | $0.00 | |
| 1158F | 65,318 | 62,342 | $0.00 | |
| 3077F | 12,214 | 11,557 | $0.00 | |
| 3078F | 112,513 | 105,322 | $0.00 | |
| Z6400 | 2,708 | 2,187 | $0.00 | |
| 87512 | 110 | 110 | $0.00 | |
| 86003 | 339 | 336 | $0.00 | |
| 88175 | Cytopathology, cervical or vaginal, any reporting system; collected in preservative fluid, automated thin layer | 4,874 | 4,855 | $0.00 |
| 1159F | 10,516 | 9,497 | $0.00 | |
| 0575F | 11,150 | 11,017 | $0.00 | |
| Z6500 | 12 | 12 | $0.00 | |
| 84450 | 118 | 117 | $0.00 | |
| 90461 | 7,673 | 5,653 | $0.00 | |
| 84550 | 368 | 366 | $0.00 | |
| 0502F | 7,667 | 5,541 | $0.00 | |
| 99242 | 65 | 65 | $0.00 | |
| 76802 | 223 | 216 | $0.00 | |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | 18,732 | 17,407 | $0.00 |
| 91313 | 92 | 92 | $0.00 | |
| 80074 | 981 | 978 | $0.00 | |
| 86735 | 75 | 75 | $0.00 | |
| 84146 | 268 | 266 | $0.00 | |
| 85610 | 1,336 | 1,042 | $0.00 | |
| 82272 | 2,641 | 2,621 | $0.00 | |
| 87254 | 12 | 12 | $0.00 | |
| 85044 | 61 | 61 | $0.00 | |
| 86708 | 1,245 | 1,240 | $0.00 | |
| 73610 | 71 | 70 | $0.00 | |
| 84439 | 3,459 | 3,431 | $0.00 | |
| 3046F | 572 | 539 | $0.00 | |
| 86039 | 120 | 120 | $0.00 | |
| 80076 | 416 | 411 | $0.00 | |
| 82785 | 264 | 264 | $0.00 | |
| 87177 | 73 | 73 | $0.00 | |
| 77067 | Screening mammography, bilateral, including computer-aided detection | 613 | 608 | $0.00 |
| 86431 | 238 | 238 | $0.00 | |
| J7699 | Noc drugs, inhalation solution administered through dme | 79 | 79 | $0.00 |
| 82274 | 2,650 | 2,631 | $0.00 | |
| 87660 | 876 | 865 | $0.00 | |
| 3045F | 478 | 407 | $0.00 | |
| 99442 | 640 | 584 | $0.00 | |
| 72100 | 83 | 82 | $0.00 | |
| 87075 | 236 | 229 | $0.00 | |
| 86038 | 374 | 372 | $0.00 | |
| Z6308 | 12 | 12 | $0.00 | |
| 76813 | 94 | 93 | $0.00 | |
| 76805 | Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation | 441 | 426 | $0.00 |
| 83013 | 233 | 233 | $0.00 | |
| 87338 | 621 | 615 | $0.00 | |
| 11981 | 206 | 197 | $0.00 | |
| 71046 | Radiologic examination, chest; 2 views | 326 | 326 | $0.00 |
| 86480 | 2,782 | 2,756 | $0.00 | |
| J2930 | Injection, methylprednisolone sodium succinate, up to 125 mg | 255 | 243 | $0.00 |
| 73130 | 27 | 27 | $0.00 | |
| 83540 | 711 | 707 | $0.00 | |
| 90687 | 128 | 116 | $0.00 | |
| G8431 | Screening for depression is documented as being positive and a follow-up plan is documented | 278 | 277 | $0.00 |
| 84702 | 612 | 492 | $0.00 | |
| 81003 | 236 | 236 | $0.00 | |
| 84403 | 306 | 302 | $0.00 | |
| 88302 | 484 | 481 | $0.00 | |
| 76814 | 96 | 95 | $0.00 | |
| Z6304 | 106 | 106 | $0.00 | |
| 85007 | 245 | 244 | $0.00 | |
| 87210 | 108 | 107 | $0.00 | |
| 2024F | 460 | 314 | $0.00 | |
| 73630 | 46 | 46 | $0.00 | |
| J7307 | Etonogestrel (contraceptive) implant system, including implant and supplies | 117 | 117 | $0.00 |
| 82947 | 144 | 141 | $0.00 | |
| 85045 | 62 | 61 | $0.00 | |
| 91321 | 41 | 27 | $0.00 | |
| 81220 | CFTR (cystic fibrosis transmembrane conductance regulator) gene analysis; common variants | 97 | 97 | $0.00 |
| 96152 | 204 | 199 | $0.00 | |
| 84460 | 168 | 167 | $0.00 | |
| 86235 | 50 | 50 | $0.00 | |
| 86765 | 81 | 81 | $0.00 | |
| 3051F | 116 | 103 | $0.00 | |
| 99204 | Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity | 105 | 103 | $0.00 |
| 99244 | Office or other outpatient consultation, moderate to high complexity | 103 | 103 | $0.00 |
| 59425 | 309 | 225 | $0.00 | |
| 2022F | 29 | 29 | $0.00 | |
| 87400 | 180 | 180 | $0.00 | |
| 86200 | 26 | 26 | $0.00 | |
| 73030 | 137 | 137 | $0.00 | |
| 90473 | 61 | 47 | $0.00 | |
| 87799 | 110 | 110 | $0.00 | |
| 84100 | 32 | 31 | $0.00 | |
| 73220 | 113 | 112 | $0.00 | |
| Z6300 | 71 | 71 | $0.00 | |
| 73562 | 144 | 144 | $0.00 | |
| 87045 | 78 | 77 | $0.00 | |
| Z6200 | 71 | 71 | $0.00 | |
| Z6414 | 15 | 14 | $0.00 | |
| 99348 | 67 | 57 | $0.00 | |
| 87481 | 110 | 110 | $0.00 | |
| 99201 | 12 | 12 | $0.00 | |
| 83721 | 27 | 26 | $0.00 | |
| 99199 | Unlisted special service, procedure or report | 44 | 37 | $0.00 |
| 17110 | 30 | 30 | $0.00 | |
| 82652 | 12 | 12 | $0.00 | |
| 98960 | 12 | 12 | $0.00 | |
| 91312 | 12 | 12 | $0.00 | |
| 86696 | 15 | 15 | $0.00 | |
| Z6208 | 12 | 12 | $0.00 | |
| 74018 | 12 | 12 | $0.00 | |
| 0521 | 72 | 38 | $0.00 | |
| 87209 | 61 | 61 | $0.00 | |
| 59426 | 17 | 15 | $0.00 | |
| 73702 | 12 | 12 | $0.00 | |
| 91320 | 17 | 12 | $0.00 | |
| 86787 | 13 | 13 | $0.00 | |
| S0119 | Ondansetron, oral, 4 mg (for circumstances falling under the medicare statute, use hcpcs q code) | 26 | 25 | $0.00 |
| 11720 | 13 | 13 | $0.00 | |
| 87798 | Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism | 12 | 12 | $0.00 |
| 81508 | 15,708 | 15,577 | $0.00 | |
| 82607 | 902 | 901 | $0.00 | |
| 3074F | 111,024 | 103,915 | $0.00 | |
| 3008F | 8,539 | 8,100 | $0.00 | |
| 3351F | 146,651 | 130,411 | $0.00 | |
| 1125F | 32,011 | 31,094 | $0.00 | |
| 3079F | 26,327 | 25,398 | $0.00 | |
| G0447 | Face-to-face behavioral counseling for obesity, 15 minutes | 83,758 | 75,183 | $0.00 |
| 86361 | 1,371 | 1,356 | $0.00 | |
| 80048 | Basic metabolic panel (calcium, ionized) | 1,125 | 1,107 | $0.00 |
| G9226 | Foot examination performed (includes examination through visual inspection, sensory exam with 10-g monofilament plus testing any one of the following: vibration using 128-hz tuning fork, pinprick sensation, ankle reflexes, or vibration perception threshold, and pulse exam; report when all of the 3 components are completed) | 3,317 | 3,115 | $0.00 |
| 73615 | 81 | 81 | $0.00 | |
| 83550 | 686 | 685 | $0.00 | |
| 0503F | 95 | 73 | $0.00 | |
| 87081 | 557 | 555 | $0.00 | |
| 86592 | 6,465 | 6,412 | $0.00 | |
| 86702 | 12,818 | 12,741 | $0.00 | |
| 86701 | 12,833 | 12,756 | $0.00 | |
| 0501F | 7,376 | 5,250 | $0.00 | |
| 3075F | 15,024 | 14,622 | $0.00 | |
| 86706 | 1,656 | 1,641 | $0.00 | |
| 73722 | 81 | 81 | $0.00 | |
| 87661 | Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe | 572 | 568 | $0.00 |
| 82043 | 8,353 | 8,257 | $0.00 | |
| 82270 | 2,648 | 2,628 | $0.00 | |
| Z1034 | 6,587 | 4,915 | $0.00 | |
| 86704 | 143 | 143 | $0.00 | |
| 83735 | 169 | 168 | $0.00 | |
| 84436 | 14 | 14 | $0.00 | |
| 3080F | 2,119 | 1,992 | $0.00 | |
| 87536 | 1,447 | 1,425 | $0.00 | |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | 3,437 | 3,426 | $0.00 |
| 87510 | 873 | 862 | $0.00 | |
| 87625 | 4,386 | 4,374 | $0.00 | |
| 86140 | 526 | 525 | $0.00 | |
| 87624 | Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types | 3,349 | 3,340 | $0.00 |
| Z6410 | 2,078 | 1,738 | $0.00 | |
| 81005 | 81 | 81 | $0.00 | |
| 57454 | 227 | 227 | $0.00 | |
| 88142 | 269 | 269 | $0.00 | |
| 3353F | 1,662 | 1,413 | $0.00 | |
| 82746 | 848 | 847 | $0.00 | |
| 3352F | 354 | 302 | $0.00 | |
| 87480 | 872 | 861 | $0.00 | |
| 85651 | 764 | 761 | $0.00 | |
| 82150 | 115 | 115 | $0.00 | |
| D0150 | Comprehensive oral evaluation - new or established patient | 157 | 155 | $0.00 |
| 82550 | 124 | 124 | $0.00 | |
| 87340 | 627 | 623 | $0.00 | |
| 3044F | 601 | 560 | $0.00 | |
| 83690 | 390 | 389 | $0.00 | |
| 83002 | 329 | 328 | $0.00 | |
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | 493 | 490 | $0.00 |
| 82271 | 2,642 | 2,623 | $0.00 | |
| 87046 | 79 | 78 | $0.00 | |
| 99241 | 341 | 335 | $0.00 | |
| Z6406 | 104 | 104 | $0.00 | |
| 82951 | 38 | 38 | $0.00 | |
| 87205 | 195 | 190 | $0.00 | |
| 0500F | 116 | 104 | $0.00 | |
| Z6204 | 134 | 133 | $0.00 | |
| Z1038 | 160 | 152 | $0.00 | |
| 93000 | 1,382 | 1,354 | $0.00 | |
| 82728 | 635 | 632 | $0.00 | |
| 96150 | 152 | 152 | $0.00 | |
| 84703 | 666 | 543 | $0.00 | |
| 3072F | 38 | 38 | $0.00 | |
| 82950 | 1,042 | 1,034 | $0.00 | |
| 85730 | 433 | 429 | $0.00 | |
| 84402 | 189 | 187 | $0.00 | |
| 84153 | 403 | 403 | $0.00 | |
| 45380 | Colonoscopy, flexible; with biopsy, single or multiple | 110 | 109 | $0.00 |
| 76641 | 80 | 78 | $0.00 | |
| J0456 | Injection, azithromycin, 500 mg | 155 | 152 | $0.00 |
| J2001 | Injection, lidocaine hcl for intravenous infusion, 10 mg | 66 | 65 | $0.00 |
| 86593 | 435 | 435 | $0.00 | |
| 1111F | 590 | 586 | $0.00 | |
| J7644 | Ipratropium bromide, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose form, per milligram | 142 | 134 | $0.00 |
| 87522 | Neg quan hep c or qual rna | 56 | 55 | $0.00 |
| Z6402 | 83 | 83 | $0.00 | |
| 90647 | 52 | 49 | $0.00 | |
| 84144 | 16 | 16 | $0.00 | |
| G0328 | Colorectal cancer screening; fecal occult blood test, immunoassay, 1-3 simultaneous | 385 | 379 | $0.00 |
| 58301 | 67 | 66 | $0.00 | |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | 314 | 282 | $0.00 |
| 98962 | 349 | 240 | $0.00 | |
| 97802 | 221 | 217 | $0.00 | |
| 76700 | Ultrasound, abdominal, real time with image documentation; complete | 43 | 43 | $0.00 |
| 82670 | 170 | 170 | $0.00 | |
| J2920 | Injection, methylprednisolone sodium succinate, up to 40 mg | 13 | 13 | $0.00 |
| 83519 | 204 | 204 | $0.00 | |
| 3354F | 127 | 103 | $0.00 | |
| S9452 | Nutrition classes, non-physician provider, per session | 333 | 316 | $0.00 |
| 85652 | 772 | 767 | $0.00 | |
| 84480 | 188 | 188 | $0.00 | |
| J3420 | Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg | 89 | 84 | $0.00 |
| 83001 | 432 | 431 | $0.00 | |
| 80055 | 577 | 574 | $0.00 | |
| 86695 | 12 | 12 | $0.00 | |
| 99050 | 758 | 701 | $0.00 | |
| Z1032 | 91 | 90 | $0.00 | |
| 27648 | 81 | 81 | $0.00 | |
| 76801 | 213 | 206 | $0.00 | |
| 90632 | 14 | 14 | $0.00 | |
| 86762 | 77 | 77 | $0.00 | |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 94 | 94 | $0.00 |
| 59430 | 25 | 25 | $0.00 | |
| 11976 | 67 | 65 | $0.00 | |
| 99381 | 115 | 115 | $0.00 | |
| H0033 | Oral medication administration, direct observation | 86 | 86 | $0.00 |
| 99386 | 45 | 45 | $0.00 | |
| 87906 | 12 | 12 | $0.00 | |
| 0134A | 92 | 92 | $0.00 | |
| 87255 | 12 | 12 | $0.00 | |
| 81223 | 26 | 26 | $0.00 | |
| 84479 | 14 | 14 | $0.00 | |
| 11200 | 13 | 13 | $0.00 | |
| 86800 | 13 | 12 | $0.00 | |
| 58300 | 114 | 114 | $0.00 | |
| 86225 | 33 | 33 | $0.00 | |
| 84270 | 95 | 95 | $0.00 | |
| 99349 | 51 | 46 | $0.00 | |
| 91314 | 14 | 14 | $0.00 | |
| 94760 | 33 | 33 | $0.00 | |
| D1206 | Topical application of fluoride varnish | 13 | 13 | $0.00 |
| 99283 | Emergency department visit for the evaluation and management, moderate severity | 38 | 38 | $0.00 |
| 1170F | 15 | 14 | $0.00 | |
| 3052F | 19 | 18 | $0.00 | |
| 82105 | 15 | 15 | $0.00 | |
| 58100 | 12 | 12 | $0.00 | |
| J0561 | Injection, penicillin g benzathine, 100,000 units | 17 | 13 | $0.00 |